Fertility Preservation in Cancer Patients

Submitted by PatientsEngage on 13 August 2017

Dr Shruti Mohanka, a fertility specialist and gynaecologist at Global hospital in Mumbai helps us understand how fertility preservation should addressed for all young male and female patients undergoing cancer treatment.

Fertility preservation is a critical element of improving quality of life in cancer survivors. Young children and young adults often survive cancer and may wish to have families in the future. They and their families need to be aware that preserving fertility is an option. Too often they are either too overwhelmed or too embarrassed to discuss this with their doctor. This is a discussion they must have with their medical team BEFORE the treatment begins.   

1.    Is fertility discussed with all cancer patients undergoing treatment? When is such a discussion essential?

Fertility should be discussed with all patients undergoing cancer treatment. It is imperative that fertility preservation be performed prior to initiation of cancer therapy.

2.    Which treatments and which cancers affect fertility?

Any cancer treatment that requires radiation therapy can affect a woman’s fertility. In case of reproductive cancers like ovarian and uterine cancers, surgery in the affected area can also affect chances of reproduction. 

(Bladder, Rectal, Testicular cancers are some of the cancers that affect male fertility) 

3.    What age groups are excluded from such a discussion?

Post-menopausal women, and men who have completed their family are excluded from such a discussion. Even pre-pubertal children can have their ova and sperm retrieved and stored.

4.    What fertility preservation options are available for males?

For males, fertility preservation options include semen or sperm cryopreservation. Semen cryopreservation is commonly called sperm banking or freezing. It is a procedure in which sperm is deposited, frozen and stored for either a short term(less than a year) or long term (indefinitely). The sample is screened for certain infections such as HIV, Syphilis, HTLV-1 and Hepatitis. Sperm is usually mixed with liquid nitrogen and secured at temperature of less than -196oC. This sperm can then be used in the future for IVF, artificial insemination or fertility treatment procedures.

In men, who have reproductive cancers or are unable to ejaculate sperm, sperm retrieval may be required. Testicular sperm aspiration or TESA is done with a fine needle inserted into the testicle. A percutaneous biopsy may also be done for some patients which uses a large needle and extracts more sperm.

5.    What fertility preservation options are available for females?

Fertility preservation options for females include:

  1. Egg Freezing is a standard storage method for oocytes or ova. For breast cancer patients, a medication is used to lower the estrogen levels temporarily to stimulate egg collection.
  2. Embryo freezing requires a male partner or sperm donor and takes about 2-6 weeks. It has shown to have high pregnancy rates of 59%.
  3. Ovarian tissue freezing is done for pre-pubertal girls where primordial cells are retrieved and stored.
  4. Ovarian transposition is considered for patients receiving radiation therapy to the pelvis. To prevent the ovary from the effects of radiation, it is moved to the posterior fossa via surgery.
  5. Ovarian suppression involves blocking hormones that stimulate the ovaries so that egg maturation is prevented. This is done via a medication called leuprolide.
  6. Radical Trachelectomy is the removal of the cervix and not the uterus in patients with cervical cancer. This can however increase risk of pre-term birth in future pregnancies.

6.    What are future risks of fertility preservation?

In less than 1% of cases there may be a chance of tumor cells transmitted to the ovum or sperm. To avoid any such risks, a Preimplantation Genetic Test (PGT) is done on the embryo prior to implantation to detect any abnormality.

7.    What is the average length of time for storage of ovum and sperm?

Sperm and ova can be stored for either a short term(less than a year) or long term (indefinitely).
Embryo can be frozen for 10 years.

8.    Are spouses or patients provided with counselling options?

The complete counseling is done by the doctors themselves with in-depth explanation of fertility preservation options. Most consults are done with the spouse present. For underage children (below 18 years of age), parental consent is essential.

9.    How expensive are cold storage facilities or cyropreservation?

Charges for cryopreservation vary from lab to lab but approximately it is:

Rs 25,000 for ovum collection/retrieval,
Rs 5,000 per year for ovum preservation.
Rs 5,000 per year for sperm preservation and
Rs 10,000 per year for embryo preservation.

Dr Shruti Mohanka is a fertility specialist and gynaecologist at Global hospital in Mumbai 

Community
Women's Health and Pregnancy
Cancer
Condition
Breast Cancer
Cancer
Ovarian Cancer
Changed
Thu, 11/02/2017 - 10:25

Stories

  • Chemotherapy explained in Hindi
    Do not fear Chemotherapy ! Understand Chemotherapy and how to deal with it. A great video in Hindi by SanjeevaniLifeBeyondCancer  
  • Novel Immunotherapy Vaccine Decreases Recurrence in HER2 Breast Cancer Patients
    Women with breast cancer tumors that overexpress human epidermal growth factor receptor 2 (HER2) may benefit from a novel vaccine to prevent recurrence A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression…
  • My cancer doesn't define who I am
    "I was originally diagnosed with locally advanced cancer, so that means it's advanced within in the chest. Mine was triple negative. It's the most aggressive form of cancer," she said. Her breast cancer diagnosis came in 2008. She found out about her metastatic breast cancer in January 2011, at 33 years old. "Two and half years after my original diagnosis, I found another lump," she said as she held back tears. "It varies from person to person. But my experience has been a bit of a roller…
  • Joan Lunden talks about her Breast Cancer
    How she shared the information with her kids and why - http://www.today.com/health/joan-lunden-how-i-told-my-kids-i-have-cancer-2D80186889 The choices she made in terms of treatment - http://www.people.com/article/joan-lunden-chemotherapy-cancer
  • Breast cancer drug Perjeta appears to extend patients lives
    According to reports from clinical trials, Roche’s breast cancer drug Perjeta displays “unprecedented” life-extending effects, helping patients live an average of 15.7 months longer than they would on chemotherapy and an older drug. 15.7 months is a significant amount of time for metastatic breast cancer patients, who are, on average, given two to three years to live after their diagnosis. Perjeta, then, has the capacity to increase that time by 50 to 75 percent.  http://www…
  • Did you know that womb cancer is the fourth most common cancer in women ?
    My cancer could have been caught earlier if I had been alerted about spotting between periods, heavy periods and watery blood between periods as the main symptoms of womb cancer,” she says. But when she asked NHS Choices whether there should be mention of womb cancer on the menopause pages, she received the following reply: “The problem with adding a warning about womb cancer to the menopause pages is that it may cause unnecessary panic.” And this, says Widschwendter, is the nub of the problem…
  • U.S. FDA Approves New Indication for the Use of Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
    The FDA initially approved XTANDI, an oral, once-daily androgen receptor inhibitor, in August 2012 for use in patients with metastatic CRPC who previously received docetaxel (chemotherapy). The new indication approves XTANDI for use in men with metastatic CRPC who have not received chemotherapy. Metastatic CRPC is defined as a cancer that has spread beyond the prostate gland and has progressed despite treatment to lower testosterone (i.e., with a gonadotropin-releasing hormone (GnRH) therapy or…
  • Heal Your Cancer
    Don’t fight cancer, heal it by attending to body, mind and spirit, says surgical oncologist Dr Vishal Rao. A child developing from an embryo in a mother’s womb is, in reality, a set of rapidly multiplying cells. But they are controlled and regulated. So, we choose to ‘love’ those cells. But when another set of cells multiply rapidly within our body, albeit haphazardly, we call it ‘Cancerous’! These cells are not foreign cells that have made an appearance from outside,…
  • “I was open to anything, just trying to find things to help me stay alive,” said Geoffrey Boycott
    Geoffrey Boycott describes how counting off his radiotherapy sessions like runs in cricket and Feng Shui helped him survive cancer http://www.telegraph.co.uk/sport/cricket/11080199/Geoffrey-Boycott-reve…
  • FDA approves first non-invasive home based DNA screening test for colorectal cancer
    The U.S. Food and Drug Administration approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer. Cologuard offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home. Colorectal cancer was the third most…